ATE250066T1 - Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen - Google Patents

Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen

Info

Publication number
ATE250066T1
ATE250066T1 AT98959652T AT98959652T ATE250066T1 AT E250066 T1 ATE250066 T1 AT E250066T1 AT 98959652 T AT98959652 T AT 98959652T AT 98959652 T AT98959652 T AT 98959652T AT E250066 T1 ATE250066 T1 AT E250066T1
Authority
AT
Austria
Prior art keywords
epothilones
oxiranyl
olefinic
reducing
reduction
Prior art date
Application number
AT98959652T
Other languages
English (en)
Inventor
Soong-Hoon Kim
James A Johnson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE250066T1 publication Critical patent/ATE250066T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98959652T 1997-12-04 1998-12-01 Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen ATE250066T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6754997P 1997-12-04 1997-12-04
US8256398P 1998-04-21 1998-04-21
PCT/US1998/025464 WO1999028324A1 (en) 1997-12-04 1998-12-01 A process for the reduction of oxiranyl epothilones to olefinic epothilones

Publications (1)

Publication Number Publication Date
ATE250066T1 true ATE250066T1 (de) 2003-10-15

Family

ID=26748002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959652T ATE250066T1 (de) 1997-12-04 1998-12-01 Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen

Country Status (12)

Country Link
EP (1) EP1042327B1 (de)
JP (1) JP4434484B2 (de)
KR (1) KR100574454B1 (de)
AT (1) ATE250066T1 (de)
AU (1) AU738576B2 (de)
CA (1) CA2311929A1 (de)
DE (1) DE69818304T2 (de)
ES (1) ES2207015T3 (de)
HU (1) HUP0100582A3 (de)
IL (1) IL135590A (de)
TW (1) TWI221469B (de)
WO (1) WO1999028324A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4579351B2 (ja) 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
IL138113A0 (en) * 1998-02-25 2001-10-31 Sloan Kettering Inst Cancer Synthesis of epothilones, intermediates thereto and analogues thereof
PT1169038E (pt) 1999-04-15 2012-10-26 Bristol Myers Squibb Co Inibidores cíclicos da proteína tirosina cinase
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1340498A1 (de) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Verwendung von Epothilonen zur Behandlung von mit proliferativen Prozessen assoziierten Gehirnerkrankungen
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
CN101389334A (zh) * 2002-05-20 2009-03-18 高山生物科学股份有限公司 埃坡霉素d的给药方法
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
AU2003302084A1 (en) 2002-11-15 2004-06-15 Bristol-Myers Squibb Company Open chain prolyl urea-related modulators of androgen receptor function
EP1559447A1 (de) 2004-01-30 2005-08-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Epothilonen zur Behandlung von neuronalen Konnektivitätsdefekten wie zum Beispiel Schizophrenie und Autismus
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
GB0405898D0 (en) 2004-03-16 2004-04-21 Novartis Ag Organic compounds
CN104116736A (zh) * 2008-04-24 2014-10-29 百时美施贵宝公司 埃坡霉素D在治疗包括阿尔茨海默病的τ相关疾病中的用途
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
CA2824521C (en) 2011-01-20 2016-06-28 Board Of Regents, The University Of Texas System Mri markers, delivery and extraction systems, and related methods
EP3228325A1 (de) 2011-06-10 2017-10-11 Mersana Therapeutics, Inc. Protein-polymer-wirkstoffkonjugate
CN102863474A (zh) 2011-07-09 2013-01-09 陈小平 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用
CN102993239A (zh) 2011-09-19 2013-03-27 陈小平 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物
WO2014075391A1 (zh) 2012-11-17 2014-05-22 北京市丰硕维康技术开发有限责任公司 离去基团是含氨基或烷氨基的丙二酸衍生物的铂类化合物
AU2013359506B2 (en) 2012-12-10 2018-05-24 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
EP2931316B1 (de) 2012-12-12 2019-02-20 Mersana Therapeutics, Inc. Hydroxylpolymer-heilmittelproteinkonjugate
MA38656A1 (fr) 2013-06-11 2018-05-31 Bayer Pharma AG Combinaisons pour le traitement du cancer comprenant un inhibiteur de la kinase mps-1 et un inhibiteur de la mitose
CA2926586C (en) 2013-10-11 2020-04-07 Mersana Therapeutics, Inc. Polymeric scaffold based on phf for targeted drug delivery
KR102572149B1 (ko) 2013-10-11 2023-08-30 아사나 바이오사이언시스 엘엘씨 단백질-폴리머-약물 접합체
CN103936748A (zh) * 2014-05-08 2014-07-23 成都摩尔生物医药有限公司 一种埃博霉素b内酰胺衍生物的制备方法
US11617799B2 (en) 2016-06-27 2023-04-04 Tagworks Pharmaceuticals B.V. Cleavable tetrazine used in bio-orthogonal drug activation
US11135307B2 (en) 2016-11-23 2021-10-05 Mersana Therapeutics, Inc. Peptide-containing linkers for antibody-drug conjugates
CA3066754A1 (en) 2017-06-22 2018-12-27 Mersana Therapeutics, Inc. Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates
US20210299286A1 (en) 2018-05-04 2021-09-30 Tagworks Pharmaceuticals B.V. Tetrazines for high click conjugation yield in vivo and high click release yield
ES2975330T3 (es) 2018-05-04 2024-07-04 Tagworks Pharmaceuticals B V Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno
KR20210084546A (ko) 2018-10-29 2021-07-07 메르사나 테라퓨틱스, 인코포레이티드 펩티드 함유 링커를 갖는 시스테인 조작된 항체-약물 접합체
IL289093B2 (en) 2019-06-17 2025-02-01 Tagworks Pharmaceuticals B V Compounds for a fast and efficient "click release" reaction
IL289094A (en) 2019-06-17 2022-02-01 Tagworks Pharmaceuticals B V Tetrazines for increasing the speed and yield of the "click release" reaction
CN118339280A (zh) 2021-09-06 2024-07-12 维拉克萨生物技术有限责任公司 用于真核生物中遗传密码子扩展的新型氨酰tRNA合成酶变体
KR20240105469A (ko) 2021-11-25 2024-07-05 베락사 바이오테크 게엠베하 유전자 코드 확장을 이용하는 부위-특이적 접합에 의해 제조되는 개선된 항체-페이로드 접합체 (apc)
DK4186529T3 (da) 2021-11-25 2025-08-25 Veraxa Biotech Gmbh Forbedrede antistof-payload-konjugater (apc) fremstillet ved stedspecifik konjugering ved hjælp af genetisk kodeudvidelse
WO2023104941A1 (en) 2021-12-08 2023-06-15 European Molecular Biology Laboratory Hydrophilic tetrazine-functionalized payloads for preparation of targeting conjugates
DK4314031T3 (da) 2022-02-15 2024-06-17 Tagworks Pharmaceuticals B V Maskeret il12-protein
CA3261603A1 (en) 2022-07-15 2024-01-18 Pheon Therapeutics Ltd ANTIBODY-DRUG CONJUGATES
WO2024080872A1 (en) 2022-10-12 2024-04-18 Tagworks Pharmaceuticals B.V. Strained bicyclononenes
WO2024153789A1 (en) 2023-01-20 2024-07-25 Basf Se Stabilized biopolymer composition, their manufacture and use
KR20250169530A (ko) 2023-03-10 2025-12-03 태그웍스 파마슈티컬스 비.브이. 개선된 t-링커를 갖는 트랜스-사이클로옥텐
CN121646574A (zh) 2023-07-27 2026-03-10 维拉克萨生物技术有限责任公司 亲水性反式环辛烯(hyTCO)化合物、含有该化合物的构建体和缀合物
WO2025056807A1 (en) 2023-09-15 2025-03-20 Basf Se Stabilized biopolymer composition, their manufacture and use
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
WO2025174248A1 (en) 2024-02-16 2025-08-21 Tagworks Pharmaceuticals B.V. Trans-cyclooctenes with "or gate" release
WO2026043376A1 (en) 2024-08-22 2026-02-26 Tagworks Pharmaceuticals B.V. Trans-cyclooctene formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
EP1440973A3 (de) * 1995-11-17 2004-10-20 Gesellschaft für biotechnologische Forschung mbH (GBF) Epothilonderivate, Herstellung und Mittel

Also Published As

Publication number Publication date
JP2001525324A (ja) 2001-12-11
HUP0100582A2 (hu) 2001-09-28
DE69818304T2 (de) 2004-07-01
ES2207015T3 (es) 2004-05-16
HUP0100582A3 (en) 2003-03-28
KR100574454B1 (ko) 2006-04-27
EP1042327A4 (de) 2002-07-17
JP4434484B2 (ja) 2010-03-17
KR20010031976A (ko) 2001-04-16
IL135590A (en) 2003-09-17
AU1540899A (en) 1999-06-16
EP1042327A1 (de) 2000-10-11
WO1999028324A1 (en) 1999-06-10
EP1042327B1 (de) 2003-09-17
IL135590A0 (en) 2001-05-20
HK1028401A1 (en) 2001-02-16
AU738576B2 (en) 2001-09-20
TWI221469B (en) 2004-10-01
CA2311929A1 (en) 1999-06-10
DE69818304D1 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69627613D1 (de) Verfahren zur Rückgewinnung von Substraten
DE69911195D1 (de) Verfahren zur direktoxidation von olefinen zu olefinoxiden
DE59809789D1 (de) Verfahren zur Herstellung von Propen
DE69807157D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE69708880D1 (de) Verfahren zur direkten oxidation von olefinen zu olefinoxiden
ATE237008T1 (de) Verfahren zur elektrolytischen herstellung von metallen
DE59803117D1 (de) Verfahren zur Hydrolyse von Alkylmonohalogeniden
DE69603255D1 (de) Verfahren zur modifizierung von oberflächen
DE59907520D1 (de) Verfahren zur kontinuierlichen Gewinnung von (Meth)acrylsäure
DE69808037D1 (de) Verfahren zur herstellung von hydroperoxiden
DE69608083D1 (de) Verfahren zur Produktion von Polycarbonat
DE69802534D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE59700957D1 (de) Verfahren zur Herstellung von Propen
DE69621156D1 (de) Verfahren zur Hydrierung von Nitrilen
DE69605902D1 (de) Verfahren zur stabilisierung von schlamm
DE59500390D1 (de) Verfahren zur Förderung von Erdöl
DE59803517D1 (de) Einstufiges verfahren zur herstellung von glykolmonoethern aus olefinen
DE69633579D1 (de) Verfahren zur Rückgewinnung von Quecksilber
DE59607103D1 (de) Verfahren zur gewinnung von 2-hydroxy-4-methylthiobuttersäure (mha)
DE69806074D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE69826869D1 (de) Verfahren zur herstellung von druckempfindlichen klebstoffen
DE69403571D1 (de) Verfahren zur Herstellung von Acrylamid
DE69830722D1 (de) Verfahren zur rückgewinnung von ölen
DE69928463D1 (de) Verfahren zur Herstellung von Stahlkomponenten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042327

Country of ref document: EP